Diaceutics virtual event: Unlocking the Future of Solid Tumor Treatment
Diaceutics to host ‘Precision Medicine in Solid Tumors’ virtual event on July 18, 2023, spotlighting the latest advancements and discussing the future of personalized cancer treatment.
BELFAST, NORTHERN IRELAND (PRWEB) JULY 14, 2023 Diaceutics, the leading data analytics and implementation services provider powering diagnostic commercialization for precision medicine, is excited to announce the upcoming “Precision Medicine in Solid Tumors” virtual event, a groundbreaking interactive experience that will bring together leading experts, researchers, and medical professionals from around the world.
The event, which will take place on July 18, 2023, will delve into the latest developments in precision medicine for solid tumors, highlighting the power of diagnostics and treatment, particularly in lung, gastric, and breast cancer, as well as digital pathology.
Precision medicine has revolutionized the way we approach cancer treatments, offering personalized therapies tailored to individual patients based on their genetic makeup. With solid tumors being one of the most challenging types of cancer to treat, this virtual event will shed light on the remarkable progress made in precision medicine and its potential to transform patient outcomes and serve as a platform to share knowledge, exchange ideas, and discuss novel strategies for the effective implementation of precision medicine in the context of solid tumors.
Experts will provide first-hand insights into the latest advancement in solid tumor treatment and discuss the challenges, opportunities, and future prospects of this revolutionary approach. Furthermore, the event will provide a platform for attendees to collaborate and network, with the opportunity to engage in interactive sessions, visit a virtual poster hall, engage in real-time Q&A sessions and connect with their peers, fostering a much-needed multidisciplinary approach to cancer care.
The sessions will cover a wide range of topics, including the power of diagnostics and treatment, particularly in lung, gastric, and breast cancer, as well as digital pathology. Further details on the renowned experts participating in the event can be found here:
Precision Medicine in Solid Tumors
Diaceutics, organizers of the event, provide an end-to-end solution for the launch of precision medicine diagnostics enabled by their proprietary platform DXRX, the world’s first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a global network and real-time labs.
Peter Keeling, CEO of Diaceutics, states, “We believe the Precision medicine in solid tumors event will provide value to our global lab network by providing the most up to date information in a range of exciting topics.”
Registration for this virtual event is now open, and we encourage all healthcare professionals, researchers, laboratory professionals, pathologists, and anyone interested in the field of precision medicine to secure their place today. Don’t miss this unique opportunity to be at the forefront of the latest developments in solid tumor treatment.
For further information and to register for free, click here.
About DXRX
DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-word diagnostic testing data from a global network of labs. DXRX is a digital gateway that answers the needs of all precision medicine stakeholders. Collaborations and data solutions that addresses today’s precision medicine challenges.
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharmaceutical and life science companies with solutions and technology for the commercialisation of their precision medicines, enabled by our proprietary DXRX platform.
About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.
SOURCE: CISION PR Newswire
